17 results
S-1/A
EX-1.1
GOSS
Gossamer Bio Inc
23 Jan 19
IPO registration (amended)
4:39pm
and regulations of any governmental authority including the Regulatory Agencies applicable to the ownership, testing, development, manufacture, packaging
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of any of the Company's product candidates, (collectively
8-K
EX-1.2
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
, packaging, processing, use, distribution, storage, import, export or disposal of any of the Company's product candidates, (collectively the “Health
DRS
EX-10.14
GOSS
Gossamer Bio Inc
11 Oct 18
Draft registration statement
12:00am
approvals for the Licensed Products for use in the Territory and in the Field.
(e)Commercialization Markings. All promotional materials, packaging
S-1
EX-10.18
dbfzga q7oy0s378m3
21 Dec 18
IPO registration
4:39pm
10-K
261gkrt2n
22 Mar 19
Annual report
4:45pm
DRS
9a62r2
11 Oct 18
Draft registration statement
12:00am
424B4
znadw adncls
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1
c0veme aw
21 Dec 18
IPO registration
4:39pm
S-1/A
ae4pgy3yvb kbohezoff
23 Jan 19
IPO registration (amended)
4:39pm
DRS/A
qmmpssu
29 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next